MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.

MicroRNAs (miRNAs) are a class of small noncoding RNAs that have gained status as important regulators of gene expression. Here, we investigated the function and molecular mechanisms of the miR-208 family of miRNAs in adult mouse heart physiology. We found that miR-208a, which is encoded within an intron of alpha-cardiac muscle myosin heavy chain gene (Myh6), was actually a member of a miRNA family that also included miR-208b, which was determined to be encoded within an intron of beta-cardiac muscle myosin heavy chain gene (Myh7). These miRNAs were differentially expressed in the mouse heart, paralleling the expression of their host genes. Transgenic overexpression of miR-208a in the heart was sufficient to induce hypertrophic growth in mice, which resulted in pronounced repression of the miR-208 regulatory targets thyroid hormone-associated protein 1 and myostatin, 2 negative regulators of muscle growth and hypertrophy. Studies of the miR-208a Tg mice indicated that miR-208a expression was sufficient to induce arrhythmias. Furthermore, analysis of mice lacking miR-208a indicated that miR-208a was required for proper cardiac conduction and expression of the cardiac transcription factors homeodomain-only protein and GATA4 and the gap junction protein connexin 40. Together, our studies uncover what we believe are novel miRNA-dependent mechanisms that modulate cardiac hypertrophy and electrical conduction.

[1]  Jian-Fu Chen,et al.  microRNAs and muscle disorders , 2009, Journal of Cell Science.

[2]  N. Rajewsky,et al.  Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.

[3]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[4]  T. Callis,et al.  Taking microRNAs to heart. , 2008, Trends in molecular medicine.

[5]  François Chevenet,et al.  OligoHeatMap (OHM): an online tool to estimate and display hybridizations of oligonucleotides onto DNA sequences , 2008, Nucleic Acids Res..

[6]  E. Olson,et al.  MicroRNAs flex their muscles. , 2008, Trends in genetics : TIG.

[7]  Rudolf Jaenisch,et al.  Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.

[8]  Michael D. Schneider,et al.  Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure , 2008, Proceedings of the National Academy of Sciences.

[9]  A. Baldwin,et al.  Proteasome inhibition promotes regression of left ventricular hypertrophy. , 2008, American journal of physiology. Heart and circulatory physiology.

[10]  Jian-Fu Chen,et al.  Muscling Through the microRNA World , 2008, Experimental biology and medicine.

[11]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[12]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[13]  Mahesh P. Gupta,et al.  Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. , 2007, Journal of molecular and cellular cardiology.

[14]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[15]  M. Kiriakidou,et al.  An mRNA m7G Cap Binding-like Motif within Human Ago2 Represses Translation , 2007, Cell.

[16]  Jian-Fu Chen,et al.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. , 2007, Journal of molecular and cellular cardiology.

[17]  Mattias Alenius,et al.  Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections , 2007, Nature Protocols.

[18]  Xiaoxia Qi,et al.  Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.

[19]  Michael T. McManus,et al.  Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.

[20]  Chunxiang Zhang,et al.  MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? , 2007, The American journal of pathology.

[21]  Thomas Thum,et al.  MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure , 2007, Circulation.

[22]  Danish Sayed,et al.  MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy , 2007, Circulation research.

[23]  J. G. Patton,et al.  Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate , 2007, Nature Genetics.

[24]  E. Olson,et al.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure , 2006, Proceedings of the National Academy of Sciences.

[25]  Hyung-Suk Kim,et al.  Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo , 2006, Proceedings of the National Academy of Sciences.

[26]  R. Plasterk,et al.  The diverse functions of microRNAs in animal development and disease. , 2006, Developmental cell.

[27]  K. Shyu,et al.  Myostatin expression in ventricular myocardium in a rat model of volume‐overload heart failure , 2006, European journal of clinical investigation.

[28]  S. Cook,et al.  Myostatin Regulates Cardiomyocyte Growth Through Modulation of Akt Signaling , 2006, Circulation research.

[29]  Noam Shomron,et al.  Canalization of development by microRNAs , 2006, Nature Genetics.

[30]  Jian-Fu Chen,et al.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.

[31]  Wei-Shiung Yang,et al.  Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes. , 2005, Cardiovascular research.

[32]  David I. K. Martin,et al.  MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Dongsun Cao,et al.  Bone Morphogenetic Protein Signaling Modulates Myocardin Transactivation of Cardiac Genes , 2005, Circulation research.

[34]  A. Pasquinelli,et al.  Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation , 2005, Cell.

[35]  Christine E Seidman,et al.  The genetic basis for cardiac remodeling. , 2005, Annual review of genomics and human genetics.

[36]  A. Gerdes,et al.  L-Thyroxine activates Akt signaling in the heart. , 2005, Journal of molecular and cellular cardiology.

[37]  Yong Zhao,et al.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.

[38]  J. Epstein,et al.  Homeobox Protein Hop Functions in the Adult Cardiac Conduction System , 2005, Circulation research.

[39]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[40]  J. Robbins,et al.  Impact of beta-myosin heavy chain expression on cardiac function during stress. , 2004, Journal of the American College of Cardiology.

[41]  Mauro W. Costa,et al.  Transcriptional regulation of the murine Connexin40 promoter by cardiac factors Nkx2-5, GATA4 and Tbx5. , 2004, Cardiovascular research.

[42]  Se-Jin Lee Regulation of muscle mass by myostatin. , 2004, Annual review of cell and developmental biology.

[43]  V. Ambros The functions of animal microRNAs , 2004, Nature.

[44]  K. Yamamoto,et al.  The Caenorhabditis elegans Ortholog of TRAP240, CeTRAP240/let-19, Selectively Modulates Gene Expression and Is Essential for Embryogenesis* , 2004, Journal of Biological Chemistry.

[45]  T. Braun,et al.  Myostatin mutation associated with gross muscle hypertrophy in a child. , 2004, The New England journal of medicine.

[46]  E. Olson A decade of discoveries in cardiac biology , 2004, Nature Medicine.

[47]  E. Olson,et al.  Hypertrophy of the heart: a new therapeutic target? , 2004, Circulation.

[48]  M. Kitakaze,et al.  Changes in myocardial gene expression associated with β-blocker therapy in patients with chronic heart failure , 2003 .

[49]  J. Epstein,et al.  Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. , 2003, The Journal of clinical investigation.

[50]  T. Hewett,et al.  Analysis of Myosin Heavy Chain Functionality in the Heart* , 2003, The Journal of Biological Chemistry.

[51]  R. Quaife,et al.  Coordinate Changes in Myosin Heavy Chain Isoform Gene Expression Are Selectively Associated With Alterations in Dilated Cardiomyopathy Phenotype , 2002, Molecular medicine.

[52]  R. Schwartz,et al.  Hop Is an Unusual Homeobox Gene that Modulates Cardiac Development , 2002, Cell.

[53]  Thomas M. Harris,et al.  Modulation of Cardiac Growth and Development by HOP, an Unusual Homeodomain Protein , 2002, Cell.

[54]  S. Cook,et al.  Transcriptional Effects of Chronic Akt Activation in the Heart* , 2002, The Journal of Biological Chemistry.

[55]  R. Quaife,et al.  Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. , 2002, The New England journal of medicine.

[56]  M. Kitakaze,et al.  Changes in myocardial gene expression associated with beta-blocker therapy in patients with chronic heart failure. , 2002, Journal of cardiac failure.

[57]  M. Quiñones,et al.  Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy , 2001, Circulation.

[58]  T. Mikawa,et al.  Purkinje fibers of the avian heart express a myogenic transcription factor program distinct from cardiac and skeletal muscle. , 2001, Developmental biology.

[59]  M. Yacoub,et al.  Altered connexin expression in human congestive heart failure. , 2001, Journal of molecular and cellular cardiology.

[60]  E. Braunwald,et al.  Congestive Heart Failure: Fifty Years of Progress , 2000, Circulation.

[61]  E. Morkin Control of cardiac myosin heavy chain gene expression , 2000, Microscopy research and technique.

[62]  K. Chien Genomic circuits and the integrative biology of cardiac diseases , 2000, Nature.

[63]  C. Lo,et al.  Role of gap junctions in cardiac conduction and development: insights from the connexin knockout mice. , 2000, Circulation research.

[64]  Qingbo Xu,et al.  Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. , 2000, Circulation.

[65]  T. Hewett,et al.  Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. , 2000, American journal of physiology. Heart and circulatory physiology.

[66]  J. Qin,et al.  Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. , 1999, Molecules and Cells.

[67]  G. Mitchell,et al.  Measurement of heart rate and Q-T interval in the conscious mouse. , 1998, American journal of physiology. Heart and circulatory physiology.

[68]  David L. Paul,et al.  Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block , 1998, Current Biology.

[69]  J. Pepper,et al.  Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. , 1998, Circulation.

[70]  M. Weiner,et al.  Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts. , 1997, The Journal of clinical investigation.

[71]  J E Saffitz,et al.  Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. , 1997, The Journal of clinical investigation.

[72]  N. Severs,et al.  Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy. , 1996, Heart.

[73]  H. Jongsma,et al.  Connexins in mammalian heart function , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[74]  J. Franklyn,et al.  Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. , 1996, Heart.

[75]  N. Alpert,et al.  Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. , 1995, Circulation research.

[76]  G. Fishman,et al.  Regulated expression of foreign genes in vivo after germline transfer. , 1994, The Journal of clinical investigation.

[77]  E. Morkin Regulation of Myosin Heavy Chain Genes in the Heart , 1993, Circulation.

[78]  C. Ianuzzo,et al.  The effects of triiodothyronine on cultured neonatal rat cardiac myocytes. , 1988, Journal of molecular and cellular cardiology.

[79]  B. Nadal-Ginard,et al.  Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. , 1984, The Journal of biological chemistry.

[80]  D. Black,et al.  MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. , 2007, Genes & development.

[81]  David J. Miller,et al.  Gene Regulatory Networks in the Evolution and Development of the Heart , 2006 .

[82]  Sawa Kostin,et al.  Gap junction remodeling and altered connexin43 expression in the failing human heart , 2004, Molecular and Cellular Biochemistry.

[83]  M. Lindhout,et al.  Functional and metabolic adaptation of the heart to prolonged thyroid hormone treatment. , 2003, American journal of physiology. Heart and circulatory physiology.

[84]  G. Martin,et al.  Analysis of Fgf8 gene function in vertebrate development. , 1997, Cold Spring Harbor symposia on quantitative biology.

[85]  L. Leinwand,et al.  The mammalian myosin heavy chain gene family. , 1996, Annual review of cell and developmental biology.

[86]  Anton J. Enright,et al.  Materials and Methods Figs. S1 to S4 Tables S1 to S5 References and Notes Micrornas Regulate Brain Morphogenesis in Zebrafish , 2022 .